ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

WSJ BLOG/Health: Medical Group Blinks Amid Criticism Over Drug-Data Disclosure

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.) By Peter Loftus A European medical society that hosts a major conference had planned to just let members and attendees -- including analysts and investors -- get an early look today at the results of some potentially market-moving studies. But after howls from critics saying that policy amounted to selective disclosure of data of Hepatitis C drugs being developed by Abbott Laboratories, Bristol-Myers Squibb and Gilead Sciences, the European Association for the Study of the Liver blinked, Dow Jones Newswires reports. The EASL now plans to publicly release summaries of most of the studies online on April 4, two weeks ahead of the meeting in Barcelona. Some won't be released until the April 18-22 event, but at the same time for everyone except media reporters, who'll get the typical early look to help them produce their stories. (EASL had planned to ban media registered to attend the meeting from reporting on the summaries until the event.) "EASL is making these changes in light of recent criticism of its proposed policy," the group said in a written statement. This isn't the first time a medical group has changed how it presents drug data at meetings -- a fraught issue that, when mishandled, can put organizations at risk of running afoul of securities laws. The American Society of Clinical Oncology, for instance, changed its policy and posts most study summaries online ahead of its annual scientific meeting. It used to distribute them to participants weeks ahead of the conference, but banned media from reporting on the contents until the event. "I think the days of conferences engaging in selective release of important study results are probably over," Scott Gottlieb, a physician and resident fellow at the American Enterprise Institute, tells Dow Jones. -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

Stock News for Abbott Labs (ABT)
DateTimeHeadline
04/29/201617:37:57Statement of Changes in Beneficial Ownership (4)
04/29/201603:03:00Abbott to Acquire St. Jude -- WSJ
04/29/201602:00:00Alere Says It Rejected Abbott Offer to Terminate Merger Deal
04/29/201601:53:00Alere Says It Rejected Abbott Offer to End Their Merger Deal
04/28/201617:42:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--6th Update
04/28/201610:19:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--5th Update
04/28/201608:35:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--4th Update
04/28/201608:30:00St. Jude Medical (STJ) ALERT: Johnson & Weaver, LLP Launches...
04/28/201608:25:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--3rd Update
04/28/201608:10:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--2nd Update
04/28/201608:04:00Abbott Laboratories Acquisition
04/28/201607:57:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--Update
04/28/201607:50:00Abbott Agreed to Buy St. Jude in $25 Billion Deal
04/28/201607:35:00Abbott Agreed to Buy St. Jude in $25 Billion Deal
04/28/201607:08:16Current Report Filing (8-k)
04/28/201606:50:00Abbott to Acquire St. Jude Medical
04/26/201609:30:00What's the Secret to Living a Full Life? A New Global Survey...
04/21/201609:00:00Abbott Introduces New Services and Tools to Help Labs Deliver...
04/20/201612:21:00Abbott Laboratories Revenue Hurt by Currency Exchange -- Update
04/20/201612:04:00Abbott CEO Declines to Confirm Commitment to Alere Acquisition

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad